Finney Rutten, Lila J.
Ruddy, Kathryn J.
Chlan, Linda L.
Griffin, Joan M.
Herrin, Jeph
Leppin, Aaron L.
Pachman, Deirdre R.
Ridgeway, Jennifer L.
Rahman, Parvez A.
Storlie, Curtis B.
Wilson, Patrick M.
Cheville, Andrea L.
Funding for this research was provided by:
National Cancer Institute (UM1 CA 233033)
Article History
Received: 7 January 2020
Accepted: 21 April 2020
First Online: 5 June 2020
Ethics approval and consent to participate {24}
: The protocol for this study was approved as a minimal risk study by the Mayo Clinic IRB (No. 18–007779).
: Not applicable.
: LJFR, LLC, JMG, JH, ALL, DRP, JLR, PAR, CBS, PMW, and ALC have no competing interests to declare. KJR inherited and then sold (in February 2018) stock in Merck and Co, Inc. and Pfizer, Inc.